...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution
Reply New Message
Prev Message Back To Forum Threaded View Next Message

An additional Exempt Distribution out of the USA

Exempt relied on: Foreign offering ASC Rule 72-501 (sections
4, 5 or 6)

Dated, 2023-11-17

In the form of a single Convertible Note for $6,861,000.00 (US Currency)

With 5 Mil Warrants @ 82 cents (US) expire 2028-11-17

 

Koo

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply